Literature DB >> 23155206

Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network.

Laura Julian1, Dana Serafin, Leigh Charvet, Joseph Ackerson, Ralph Benedict, Ellen Braaten, Tanya Brown, Ellen O'Donnell, Joy Parrish, Thomas Preston, Michael Zaccariello, Anita Belman, Tanuja Chitnis, Mark Gorman, Jayne Ness, Marc Patterson, Moses Rodriguez, Emmanuelle Waubant, Bianca Weinstock-Guttman, Ann Yeh, Lauren B Krupp.   

Abstract

In the largest sample studied to date, we measured cognitive functioning in children and adolescents with pediatric multiple sclerosis (n = 187) as well as those with clinically isolated syndrome (n = 44). Participants were consecutively enrolled from six United States Pediatric Multiple Sclerosis Centers of Excellence. Participants had a mean of 14.8 ± 2.6 years of age and an average disease duration of 1.9 ± 2.2 years. A total of 65 (35%) children with multiple sclerosis and 8 (18%) with clinically isolated syndrome met criteria for cognitive impairment. The most frequent areas involved were fine motor coordination (54%), visuomotor integration (50%), and speeded information processing (35%). A diagnosis of multiple sclerosis (odds ratio = 3.60, confidence interval = 1.07, 12.36, P = .04) and overall neurologic disability (odds ratio = 1.47, confidence interval = 1.10, 2.10, P = .03) were the only independent predictors of cognitive impairment. Cognitive impairment may occur early in these patients, and prompt recognition is critical for their care.

Entities:  

Mesh:

Year:  2012        PMID: 23155206      PMCID: PMC3652651          DOI: 10.1177/0883073812464816

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  21 in total

1.  Multiple sclerosis in childhood: clinical features of 149 cases.

Authors:  A Ghezzi; V Deplano; J Faroni; M G Grasso; M Liguori; G Marrosu; C Pozzilli; I L Simone; M Zaffaroni
Journal:  Mult Scler       Date:  1997-02       Impact factor: 6.312

Review 2.  The psychosocial consequences of pediatric multiple sclerosis.

Authors:  W S MacAllister; J R Boyd; N J Holland; M C Milazzo; L B Krupp
Journal:  Neurology       Date:  2007-04-17       Impact factor: 9.910

Review 3.  Consensus definitions proposed for pediatric multiple sclerosis and related disorders.

Authors:  Lauren B Krupp; Brenda Banwell; Silvia Tenembaum
Journal:  Neurology       Date:  2007-04-17       Impact factor: 9.910

4.  Cognitive functioning in children and adolescents with multiple sclerosis.

Authors:  W S MacAllister; A L Belman; M Milazzo; D M Weisbrot; C Christodoulou; W F Scherl; T E Preston; C Cianciulli; L B Krupp
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

5.  Memory performance and normalized regional brain volumes in patients with pediatric-onset multiple sclerosis.

Authors:  Amanda Fuentes; Donald Louis Collins; Daniel Garcia-Lorenzo; John G Sled; Sridar Narayanan; Douglas L Arnold; Brenda L Banwell; Christine Till
Journal:  J Int Neuropsychol Soc       Date:  2012-02-10       Impact factor: 2.892

6.  Cognitive impairment in probable multiple sclerosis.

Authors:  A Achiron; Y Barak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

7.  The cognitive burden of multiple sclerosis in children.

Authors:  Brenda L Banwell; Peter E Anderson
Journal:  Neurology       Date:  2005-03-08       Impact factor: 9.910

8.  Multiple sclerosis in childhood: clinical profile in 125 patients.

Authors:  P Duquette; T J Murray; J Pleines; G C Ebers; D Sadovnick; P Weldon; S Warren; D W Paty; A Upton; W Hader
Journal:  J Pediatr       Date:  1987-09       Impact factor: 4.406

9.  Cognitive and psychosocial features of childhood and juvenile MS.

Authors:  M P Amato; B Goretti; A Ghezzi; S Lori; V Zipoli; E Portaccio; L Moiola; M Falautano; M F De Caro; M Lopez; F Patti; R Vecchio; C Pozzilli; V Bianchi; M Roscio; G Comi; M Trojano
Journal:  Neurology       Date:  2008-05-13       Impact factor: 9.910

10.  Longitudinal neuropsychological assessment in pediatric multiple sclerosis.

Authors:  William S MacAllister; Christopher Christodoulou; Maria Milazzo; Lauren B Krupp
Journal:  Dev Neuropsychol       Date:  2007       Impact factor: 2.253

View more
  37 in total

1.  Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network.

Authors:  L E Charvet; E H O'Donnell; A L Belman; T Chitnis; J M Ness; J Parrish; M Patterson; M Rodriguez; E Waubant; B Weinstock-Guttman; L B Krupp
Journal:  Mult Scler       Date:  2014-03-31       Impact factor: 6.312

2.  Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT).

Authors:  J Burman; K Kirgizov; K Carlson; M Badoglio; G L Mancardi; G De Luca; B Casanova; J Ouyang; R Bembeeva; J Haas; P Bader; J Snowden; D Farge
Journal:  Bone Marrow Transplant       Date:  2017-03-20       Impact factor: 5.483

3.  Differentiation of Cognitive Deficit Profiles in Multiple Sclerosis Patients: Latent Profile Analysis.

Authors:  Sanela Slavković; Milica Lazić; Cynthia Honan; Čongor Nađ; Nina Brkić-Jovanović; Špela Golubović
Journal:  Med Princ Pract       Date:  2019-03-04       Impact factor: 1.927

Review 4.  Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.

Authors:  Amy Waldman; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu; Brenda Banwell
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

5.  Fingolimod as first-line treatment in pediatric-onset multiple sclerosis: a case report.

Authors:  Marco Capobianco; Antonio Bertolotto; Simona Malucchi
Journal:  Neurol Sci       Date:  2021-03-12       Impact factor: 3.307

6.  Treatment of pediatric multiple sclerosis.

Authors:  Sona Narula; Sarah E Hopkins; Brenda Banwell
Journal:  Curr Treat Options Neurol       Date:  2015-03       Impact factor: 3.598

7.  Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis.

Authors:  Gregory Aaen; Michael Waltz; Wendy Vargas; Naila Makhani; Jayne Ness; Yolanda Harris; T Charles Casper; Leslie Benson; Meghan Candee; Tanuja Chitnis; Mark Gorman; Jennifer Graves; Benjamin Greenberg; Timothy Lotze; Soe Mar; Jan-Mendelt Tillema; Mary Rensel; Moses Rodriguez; John Rose; Jennifer Rubin; Teri Schreiner; Amy Waldman; Bianca Weinstock-Guttman; Anita Belman; Emmanuelle Waubant; Lauren Krupp
Journal:  J Child Neurol       Date:  2018-12-17       Impact factor: 1.987

8.  The educational impact of childhood-onset multiple sclerosis: Why assessing academic achievement is imperative.

Authors:  W S Vargas; K G Noble; B Banwell; P De Jager
Journal:  Mult Scler       Date:  2020-05-28       Impact factor: 6.312

Review 9.  Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.

Authors:  J Nicholas Brenton; Brenda L Banwell
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

10.  No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumab.

Authors:  Monica Margoni; Francesca Rinaldi; Alice Riccardi; Silvia Franciotta; Paola Perini; Paolo Gallo
Journal:  J Neurol       Date:  2019-09-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.